Dr Shabbir Susnerwala is a Consultant Clinical Oncologist based at The Rosemere Cancer Centre at the Royal Preston Hospital.

Dr Susnerwala qualified in oncology at Bombays largest cancer hospital, the Tata Memorial Hospital and was appointed as a consultant oncologist in 1989. He decided to move to the UK in 1992 and joined Europe's largest cancer centre, The Christie Hospital, Manchester where he consolidated his oncological experience. In 1996 he was appointed as Consultant Clinical Oncologist at the newly established Rosemere Cancer Centre.

He specialises in the treatment of Colorectal, Breast and Urological cancers. His expertise have been widely sought for many years both in clinical practice and education and he has held a number of positions that reflect this. These include Clinical Director for Oncology Services, Educational Supervisor, College Tutor (Royal College of Radiologists), Overseas Doctors Mentor, Member of Postgraduate Committee (Royal Preston Hospital), Audit Lead for Oncology,  Lead Cancer Clinician for Lancashire Teaching Hospital chain and is a member of the Clinical Governance Committee for Oncology.

Dr Susnerwala is a member of The Royal College of Radiologists and speaks English, Gujarati and Hindi.

Dr Andrew Hindley is a Consultant Clinical Oncologist based at The Cancer Centre at Royal Preston Hospital.

Dr Hindley qualified at Birmingham University Medical School in 1977, having been on a travelling scholarship to Malaysia. His elective was spent in oncology at the University of Heidelberg. After training in General Medicine he worked at the Christie Hospital in Clinical Pharmacology, learning how to use anti-cancer drugs, safely and effectively, and carried out research into hormone therapy of breast cancer. He then underwent training in radiotherapy and first became a Consultant in New Zealand prior to taking up his current consultant appointment at Royal Preston Hospital in 1997. 

His clinical interests are in breast cancer, lung cancer, gynaecological, central nervous system and skin cancer. He is actively involved in research into new treatments and training medical students and junior doctors.

His publications have covered hormone therapy and breast cancer, radiotherapy for gynaecological cancer and head and neck cancer, and chemotherapy for gynaecological cancer. His clinical interests are in breast cancer, lung cancer, gynaecological, central nervous system and skin cancer.

In addition to his clinical role Dr Hindley is the Network Clinical Lead for Research and is committed to improving cancer treatment and supportive care for patients in clinical trials. His particular research interests include chemotherapy for platinum resistant disease in ovarian cancer, overcoming unwanted effects of radiotherapy and development of new treatments for brain tumours.